Quadrant Capital Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Quadrant Capital Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-189	Closed	-$3K	–	2276
2018 Q1	$3K	Hold	189	–	–	﹤0.01%	1775
2017 Q4	$2K	Hold	189	–	–	﹤0.01%	1883
2017 Q3	$3K	Hold	189	–	–	﹤0.01%	1718
2017 Q2	$0	Buy	189 +70	+59%	+$1.03K	﹤0.01%	2193
2017 Q1	$1K	Buy	119 +16	+16%	+$193	﹤0.01%	1990
2016 Q4	$1K	Buy	103 +45	+78%	+$769	﹤0.01%	1912
2016 Q3	$1K	Buy	58 +34	+142%	+$914	﹤0.01%	1908
2016 Q2	$0	Sell	24 -179	-88%	-$5.83K	﹤0.01%	2143
2016 Q1	$5K	Buy	+203	New	+$7.14K	﹤0.01%	1198

Quadrant Capital Group's IPXL Position: Q2 2018 in Review

Quadrant Capital Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 189 shares — an estimated $3K sold.

Quadrant Capital Group first reported a position in IPXL in Q1 2016 and held it in 9 quarters. The position peaked at $5K in Q1 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Quadrant Capital Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Quadrant Capital Group sold 189 Impax Laboratories, Inc. shares in Q2 2018, an estimated $3K.
Quadrant Capital Group first reported a position in Impax Laboratories, Inc. in Q1 2016 and held it in 9 quarters.
Quadrant Capital Group's Impax Laboratories, Inc. position peaked at $5K in Q1 2016.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Quadrant Capital Group's 13F filing for Q2 2018, filed 9 Aug 2018.